Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies

Glioblastoma (GBM) is the most common primary adult brain tumor, characterized by extensive cellular and genetic heterogeneity. Even with surgery, standard chemotherapy, and radiation, tumor recurrence and patient relapse are inevitable with a median survival rate of

Intern: 
Nicolas Yelle
Allison Nixon
Jaspal Singh
Megha Chandrashekhar
Faculty Supervisor: 
Sheila Kumari Singh
Jason Moffat
Province: 
Ontario
Sector: 
Partner University: 
Program: